GPC
51
-2
APA
25
2
NFLX
62
4
EMN
46
-2
GWW
41
-5
DD
34
-2
ICE
69
3
AAP
20
3
VTR
54
2
ED
56
-3
NTAP
37
2
NDAQ
56
3
DNB
40
2
FTI
46
3
AEP
66
-3
KEY
36
9
LRCX
49
7
DLTR
36
-2
CAT
40
-2
GOOGL
45
5
GPC
51
-2
APA
25
2
NFLX
62
4
EMN
46
-2
GWW
41
-5
DD
34
-2
ICE
69
3
AAP
20
3
VTR
54
2
ED
56
-3
NTAP
37
2
NDAQ
56
3
DNB
40
2
FTI
46
3
AEP
66
-3
KEY
36
9
LRCX
49
7
DLTR
36
-2
CAT
40
-2
GOOGL
45
5
Financhill
Back

BlackRock Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
40

BLK
BlackRock

Last Price:
$900.96
Seasonality Move:
4.71%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.13
Seasonality Move:
6.73%
Sell
40
BlackRock (BLK) is a Sell

Is BlackRock a Buy, Sell or Hold?

  • The current BlackRock [BLK] share price is $910.06. The Score for BLK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BLK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BLK Stock Price Chart

What is BlackRock's stock price today?

  • The BlackRock share price today is $910.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLK is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -20.15 Sell
Relative Strength Index (14 RSI): 32.21 Sell
Chaikin Money Flow: -218876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (945.76 - 999.84) Sell
Bollinger Bands (100): (974.62 - 1044.06) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

BLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 948.9 Sell
20-day SMA: 963.87 Sell
50-day SMA: 995.37 Sell
200-day SMA: 929.78 Sell
8-day EMA: 940.59 Sell
20-day EMA: 962.44 Sell
50-day EMA: 985.32 Sell
200-day EMA: 939.18 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

BlackRock Earnings Growth & BLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.22 per share, an increase next quarter of $0.07 per share, an increase this year of $4.41 per share, and an increase next year of $6.60 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

BlackRock Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):